ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1972

Cardiovascular and Cerebrovascular Disease and Social Deprivation in Patients with Giant Cell Arteritis

Joanna Robson1, Amit Kiran2, Andrew Hutchings3, Joseph Maskell4, Nigel K Arden5, Willie Hamilton6, Bhaskar Dasgupta7,8 and Raashid Luqmani9, 1Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Sciences, University of Oxford, University of Oxford, Oxford, United Kingdom, 2Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Science, University of Oxford, Oxford, United Kingdom, 3Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom, 4Faculty of Medicine, University of Southampton, Southampton, United Kingdom, 5Oxford NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, United Kingdom, 6Primary Care, University of Exeter, Exeter, United Kingdom, 7Southend University Hospital, Southend, United Kingdom, 8Rheumatology, Southend University Hospital, Essex, United Kingdom, 9Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Cardiovascular disease, Cerebrovascular disease, Epidemiologic methods, giant cell arteritis and socio-economic inequities

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Vasculitis Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Giant cell arteritis (GCA) is the
most common form of vasculitis in the UK, with an incidence of 2.2 cases per 10,000
person-years. Cerebrovascular and cardiovascular disease may be increased in
patients with GCA but risk factors are not confirmed. Social deprivation may be
associated with visual ischaemic complications in
GCA. This study evaluated the risk of cerebrovascular and cardiovascular disease
in patients with GCA compared with matched controls, and identified predictors of
these outcomes.

Methods: A UK General Practice Research Database
(GPRD) from 1991 to 2001 was used for a parallel cohort study of 5,827 patients
with GCA and 37,090 controls, matched on age, gender and location (GP practice).A multivariable
competing risk model (non-cardiovascular related death as the competing risk)
determined the relative risk (subhazard ratio, SHR)
between non-GCA and GCA patients for each of the following outcomes
“cerebrovascular disease”, “cardiovascular disease” or “cardiovascular or
cerebrovascular disease” (three analyses). The model adjusted for smoking
history, history of hypertension, prior use of anti-hypertensives,
history of diabetes or prior use of diabetic medications, history of hyperlipidaemia, prior use of lipid- lowering medications)
and Index of Multiple Deprivation (IMD) quintiles. The model was then run on
each cohort separately to identify predictors of cerebrovascular and cardiovascular
disease (age and gender were now included).

Results: Comparing the GCA cohort with the non-GCA
cohort, the SHR (95% CI) for cerebrovascular disease (1.45 [1.31-1.60]),
cardiovascular disease (1.49 [1.37-1.62]) and for cerebrovascular or
cardiovascular disease (1.47 [1.37-1.57]) were increased. In the GCA cohort only,
predictors of the composite outcome of “cardiovascular or cerebrovascular
disease” included increasing age (1.98 (1.62-2.42), p<0.001 for patients
>80 compared with those <65 years); male gender (1.20 (1.05-1.38),
p<0.001) and those in the most deprived IMD quintile compared with the least
deprived (1.34 (1.01-1.78), p<0.05).  A history of hypertension was predictive of
cardiovascular disease within the GCA cohort (1.53 (1.14-2.05), p<0.01) but
no other significant associations were seen between the other conventional
cardiovascular risk factors and either cardiovascular or cerebrovascular
disease as either separate or composite outcomes.

Conclusion: Patients with GCA are fifty percent more
likely to have cerebrovascular disease or cardiovascular disease than age, gender
and location matched controls. This effect is independent of conventional
cardiovascular risk factors but may be associated with higher levels of social deprivation.

Figure 1. Cumulative incidence of cerebrovascular and cardiovascular
disease by level of social deprivation in patients with and without giant cell
arteritis


Disclosure: J. Robson, None; A. Kiran, None; A. Hutchings, None; J. Maskell, None; N. K. Arden, None; W. Hamilton, None; B. Dasgupta, GSK, Servier,UCB, 5; R. Luqmani, GSK, 5,Chemocentryx, 5,Roche Pharmaceuticals, 5.

To cite this abstract in AMA style:

Robson J, Kiran A, Hutchings A, Maskell J, Arden NK, Hamilton W, Dasgupta B, Luqmani R. Cardiovascular and Cerebrovascular Disease and Social Deprivation in Patients with Giant Cell Arteritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/cardiovascular-and-cerebrovascular-disease-and-social-deprivation-in-patients-with-giant-cell-arteritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cardiovascular-and-cerebrovascular-disease-and-social-deprivation-in-patients-with-giant-cell-arteritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology